ARROWHEAD PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Arrowhead Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $45.3M, a 0.09% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $45.3M -$42K -0.09% Sep 30, 2024 10-K 2024-11-26
Q2 2024 $44.3M +$3.67M +9.03% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $44.6M +$3.51M +8.54% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $44.9M +$3.25M +7.81% Dec 31, 2023 10-Q 2024-02-06
Q3 2023 $45.3M -$13M -22.3% Sep 30, 2023 10-K 2024-11-26
Q2 2023 $40.7M -$28.2M -41% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $41.1M +$24.7M +151% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $41.7M +$24.8M +147% Dec 31, 2022 10-Q 2023-02-06
Q3 2022 $58.3M +$40.9M +236% Sep 30, 2022 10-K 2023-11-29
Q2 2022 $68.9M +$50.5M +273% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $16.4M -$1.99M -10.8% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $16.9M +$1.13M +7.16% Dec 31, 2021 10-Q 2022-02-02
Q3 2021 $17.3M +$1.21M +7.49% Sep 30, 2021 10-K 2022-11-28
Q2 2021 $18.5M +$1.93M +11.7% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $18.4M +$8.11M +79% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $15.7M +$5.31M +50.8% Dec 31, 2020 10-Q 2021-02-04
Q3 2020 $16.1M Sep 30, 2020 10-K 2021-11-22
Q2 2020 $16.5M Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $10.3M Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $10.4M Dec 31, 2019 10-Q 2020-02-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.